Works matching AU Kurkjian, Carla


Results: 12
    1
    2
    3
    4
    5
    6
    7

    Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 2, p. 419, doi. 10.1007/s10637-019-00776-6
    By:
    • Shapiro, Geoffrey I.;
    • LoRusso, Patricia;
    • Kwak, Eunice;
    • Pandya, Susan;
    • Rudin, Charles M.;
    • Kurkjian, Carla;
    • Cleary, James M.;
    • Pilat, Mary Jo;
    • Jones, Suzanne;
    • de Crespigny, Alex;
    • Fredrickson, Jill;
    • Musib, Luna;
    • Yan, Yibing;
    • Wongchenko, Matthew;
    • Hsieh, Hsin-Ju;
    • Gates, Mary R.;
    • Chan, Iris T.;
    • Bendell, Johanna
    Publication type:
    Article
    8

    A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z
    By:
    • Aghajanian, Carol;
    • Bell-McGuinn, Katherine M.;
    • Burris, Howard A.;
    • Siu, Lillian L.;
    • Stayner, Lee-Ann;
    • Wheler, Jennifer J.;
    • Hong, David S.;
    • Kurkjian, Carla;
    • Pant, Shubham;
    • Santiago-Walker, Ademi;
    • Gauvin, Jennifer L.;
    • Antal, Joyce M.;
    • Opalinska, Joanna B.;
    • Morris, Shannon R.;
    • Infante, Jeffrey R.
    Publication type:
    Article
    9
    10
    11
    12